5. Progressive supranuclear palsy Clinical trials / Disease details

Clinical trials : 89 / Drugs : 107 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-000422-38-SE (EUCTR)	19/09/2014	05/08/2014	A study evaluating the diagnostic accuracy of [18F]-AV-1451 PET to detect and distinguish neurodegen ...	An open-label study evaluating the diagnostic accuracy of [18F]-AV-1451 PET to detect and distinguis ...	Neurodegenerative disorders with Tau-pathology; including Alzheimer's disease, progressive supranucl ...	Product Name: 18F-AV-1451	Skåne University Hospital, Region Skåne	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Sweden
2	NCT02167594 (ClinicalTrials.gov)	August 12, 2014	17/6/2014	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy V ...	18F-AV-1451Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), ...	Progressive Supranuclear Palsy;Corticobasal Degeneration	Drug: Flortaucipir F18;Procedure: Brain PET scan	Avid Radiopharmaceuticals	NULL	Completed	50 Years	85 Years	All	29	Phase 1	United States

First Previous1Next Last